IJR | SMDV | IJR / SMDV | |
Gain YTD | -1.961 | 1.360 | -144% |
Net Assets | 85.4B | 715M | 11,944% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 19.00 | 33.00 | 58% |
Yield | 1.28 | 2.74 | 47% |
Fund Existence | 25 years | 10 years | - |
IJR | SMDV | |
---|---|---|
RSI ODDS (%) | 3 days ago90% | N/A |
Stochastic ODDS (%) | 3 days ago87% | 3 days ago80% |
Momentum ODDS (%) | 3 days ago81% | 3 days ago81% |
MACD ODDS (%) | 3 days ago84% | 6 days ago80% |
TrendWeek ODDS (%) | 3 days ago83% | 3 days ago81% |
TrendMonth ODDS (%) | 3 days ago84% | 3 days ago82% |
Advances ODDS (%) | 19 days ago85% | 13 days ago86% |
Declines ODDS (%) | 3 days ago85% | 3 days ago83% |
BollingerBands ODDS (%) | 3 days ago90% | N/A |
Aroon ODDS (%) | 3 days ago83% | 3 days ago74% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BSCQ | 19.53 | 0.02 | +0.10% |
Invesco BulletShares 2026 Corp Bd ETF | |||
HYZD | 22.48 | -0.05 | -0.22% |
WisdomTree Interest Rt Hdg Hi Yld Bd ETF | |||
SMIN | 65.01 | -1.26 | -1.90% |
iShares MSCI India Small-Cap ETF | |||
AWAY | 22.20 | -0.47 | -2.07% |
Amplify Travel Tech ETF | |||
CNCR | 12.30 | -0.27 | -2.15% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, SMDV has been closely correlated with UCB. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMDV jumps, then UCB could also see price increases.
Ticker / NAME | Correlation To SMDV | 1D Price Change % | ||
---|---|---|---|---|
SMDV | 100% | -1.21% | ||
UCB - SMDV | 88% Closely correlated | -2.09% | ||
UBSI - SMDV | 88% Closely correlated | -3.37% | ||
FRME - SMDV | 87% Closely correlated | -1.54% | ||
AUB - SMDV | 87% Closely correlated | -4.08% | ||
STBA - SMDV | 85% Closely correlated | -1.80% | ||
More |